Evidence map›Paper›PMID 41244477›Full record

ArticleACS omega2025

Antifungal Efficacy of Plasma-Activated Liquids against

Sabrina de Moura Rovetta-Nogueira, Felipe de Souza Miranda, Diego Morais da Silva, Michaela Shiotani Marcondes, Rodrigo Sávio Pessoa, Cristiane Yumi Koga-Ito

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sabrina de Moura Rovetta-NogueiraInstitute of Science and Technology, São Paulo State University (UNESP), Avenida Engenheiro Francisco José Longo, 777 São José dos Campos, Brazil.
Felipe de Souza MirandaInstitute of Science and Technology, São Paulo State University (UNESP), Avenida Engenheiro Francisco José Longo, 777 São José dos Campos, Brazil.ORCID https://orcid.org/0000-0002-5012-4592
Diego Morais da SilvaInstitute of Science and Technology, São Paulo State University (UNESP), Avenida Engenheiro Francisco José Longo, 777 São José dos Campos, Brazil.ORCID https://orcid.org/0000-0003-0271-9142
Michaela Shiotani MarcondesPlasmas and Processes Laboratory, Department of Physics, Aeronautics Institute of Technology, Praça Marechal Eduardo Gomes 50, São José dos Campos 12228-900, Brazil.
Rodrigo Sávio PessoaPlasmas and Processes Laboratory, Department of Physics, Aeronautics Institute of Technology, Praça Marechal Eduardo Gomes 50, São José dos Campos 12228-900, Brazil.ORCID https://orcid.org/0000-0001-7600-9747
Cristiane Yumi Koga-ItoInstitute of Science and Technology, São Paulo State University (UNESP), Avenida Engenheiro Francisco José Longo, 777 São José dos Campos, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing incidence of oral candidiasis refractory to conventional antifungal treatments, coupled with limited therapeutic alternatives, underscores an urgent need for novel interventions. Plasma-activated liquids (PALs), generated via nonthermal plasma, have shown antimicrobial promise, yet their antifungal efficacy, particularly against

Identifiers

PMID41244477
PMCPMC12612981

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.